Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bossi

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Endocrinological Investigation|October 9, 2023
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitorsS Antonini, R Pedersini, M F Birtolo, et al.
The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Frontiers in Endocrinology|April 2, 2026
Real-world effectiveness of denosumab compared to teriparatide in patients with severe osteoporosisMaria Francesca Birtolo, Alberto Piasentier, Andreea Daniela Dutu, et al.
Plos Medicine|July 14, 2021
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) studyPiero Ruggenenti, Monica Cortinovis, Aneliya Parvanova, et al.
Journal of the Endocrine Society|April 27, 2018
Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled TrialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent GlioblastomaFabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak, et al.
Nature|June 25, 2025
Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactionsBrian M Andersen, Camilo Faust Akl, Michael A Wheeler, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2017
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trialOlga Vaccaro, Maria Masulli, Antonio Nicolucci, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Endocrinological Investigation|October 9, 2023
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitorsS Antonini, R Pedersini, M F Birtolo, et al.
The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Frontiers in Endocrinology|April 2, 2026
Real-world effectiveness of denosumab compared to teriparatide in patients with severe osteoporosisMaria Francesca Birtolo, Alberto Piasentier, Andreea Daniela Dutu, et al.
Plos Medicine|July 14, 2021
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) studyPiero Ruggenenti, Monica Cortinovis, Aneliya Parvanova, et al.
Journal of the Endocrine Society|April 27, 2018
Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled TrialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Diabetes, Obesity & Metabolism|February 23, 2019
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trialPiero Ruggenenti, Matias Trillini, Drazenka P Barlovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent GlioblastomaFabio M Iwamoto, Shyam K Tanguturi, Lakshmi Nayak, et al.
Nature|June 25, 2025
Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactionsBrian M Andersen, Camilo Faust Akl, Michael A Wheeler, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2017
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trialOlga Vaccaro, Maria Masulli, Antonio Nicolucci, et al.
Nature Communications|July 31, 2025
A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomasApril A Apfelbaum, Eric Morin, Dominik Sturm, et al.
Pageof 7